Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 30, 2026.
An initiative by the Alzheimer’s Drug Discovery Foundation (ADDF) dedicated to developing scalable, accessible tools for the earliest detection of Alzheimer's disease, particularly through speech-based and digital biomarkers.
Optimly has not yet published enough evidence to assess how often AI assistants recommend Diagnostics Accelerator (partnership).
Optimly has not yet published a supported competitor set for Diagnostics Accelerator (partnership).
Official website: https://alzdiscovery.org/
Last analyzed: August 30, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile